Changes in systemic hemodynamics during the CPT—analyses are performed with the maximal CPT (last 30 s of CPT).
| . | . | . | . | . | Univariate analysis . | Adjusted analysis . | ||
|---|---|---|---|---|---|---|---|---|
| . | Baseline . | CPT . | CPTmax . | Recovery . | Group β (P-value) . | Exposure β (P-value) . | β (P-value) . | Group × exposure β (P-value) . |
| SBP (mmHg) | ||||||||
| NT | 121 ± 9 | 136 ± 14 | 146 ± 18 | 127 ± 14 | 29.91 (P < .001) | 26.99 (P < .001) | Group: 27.08 (P < .001) | BL vs CPTmax: No interaction |
| HT | 148 ± 15 | 167 ± 24 | 178 ± 28 | 155 ± 16 | BL vs CPTmax: 24.38 (P < .001) | 5.64 (P = .228) | ||
| DBP (mmHg) | ||||||||
| NT | 70 ± 9 | 84 ± 13 | 92 ± 16 | 77 ± 10 | 20.68 (P < .001) | 21.54 (P < .001) | Group: 20.76 (P < .001) | BL vs CPTmax: No interaction |
| HT | 91 ± 11 | 106 ± 18 | 113 ± 19 | 96 ± 12 | BL vs CPTmax: 21.62 (P < .001) | –0.174 (P = .964) | ||
| MBP (mmHg) | ||||||||
| NT | 89 ± 10 | 105 ± 14 | 114 ± 17 | 97 ± 11 | 25.30 (P < .001) | 25.31 (P < .001) | Group: 24.74 (P < .001) | BL vs CPTmax: No interaction |
| HT | 114 ± 12 | 132 ± 21 | 140 ± 23 | 120 ± 13 | BL vs CPTmax: 24.80 (P < .001) | 1.11 (P = .801) | ||
| HR (b.p.m.) | ||||||||
| NT | 63 ± 10 | 76 ± 14 | 74 ± 14 | 63 ± 10 | –2.88 (P = .207) | 9.17 (P < .001) | Group: –1.47 (P = .575) | BL vs CPTmax: No interaction |
| HT | 62 ± 7 | 70 ± 12 | 69 ± 12 | 61 ± 7 | BL vs CPTmax: 10.47 (P < .001) | –2.79 (P = .296) | ||
| . | . | . | . | . | Univariate analysis . | Adjusted analysis . | ||
|---|---|---|---|---|---|---|---|---|
| . | Baseline . | CPT . | CPTmax . | Recovery . | Group β (P-value) . | Exposure β (P-value) . | β (P-value) . | Group × exposure β (P-value) . |
| SBP (mmHg) | ||||||||
| NT | 121 ± 9 | 136 ± 14 | 146 ± 18 | 127 ± 14 | 29.91 (P < .001) | 26.99 (P < .001) | Group: 27.08 (P < .001) | BL vs CPTmax: No interaction |
| HT | 148 ± 15 | 167 ± 24 | 178 ± 28 | 155 ± 16 | BL vs CPTmax: 24.38 (P < .001) | 5.64 (P = .228) | ||
| DBP (mmHg) | ||||||||
| NT | 70 ± 9 | 84 ± 13 | 92 ± 16 | 77 ± 10 | 20.68 (P < .001) | 21.54 (P < .001) | Group: 20.76 (P < .001) | BL vs CPTmax: No interaction |
| HT | 91 ± 11 | 106 ± 18 | 113 ± 19 | 96 ± 12 | BL vs CPTmax: 21.62 (P < .001) | –0.174 (P = .964) | ||
| MBP (mmHg) | ||||||||
| NT | 89 ± 10 | 105 ± 14 | 114 ± 17 | 97 ± 11 | 25.30 (P < .001) | 25.31 (P < .001) | Group: 24.74 (P < .001) | BL vs CPTmax: No interaction |
| HT | 114 ± 12 | 132 ± 21 | 140 ± 23 | 120 ± 13 | BL vs CPTmax: 24.80 (P < .001) | 1.11 (P = .801) | ||
| HR (b.p.m.) | ||||||||
| NT | 63 ± 10 | 76 ± 14 | 74 ± 14 | 63 ± 10 | –2.88 (P = .207) | 9.17 (P < .001) | Group: –1.47 (P = .575) | BL vs CPTmax: No interaction |
| HT | 62 ± 7 | 70 ± 12 | 69 ± 12 | 61 ± 7 | BL vs CPTmax: 10.47 (P < .001) | –2.79 (P = .296) | ||
Data are presented as mean ± SD.
CPTmax: maximal CPT; BL, baseline.
Changes in systemic hemodynamics during the CPT—analyses are performed with the maximal CPT (last 30 s of CPT).
| . | . | . | . | . | Univariate analysis . | Adjusted analysis . | ||
|---|---|---|---|---|---|---|---|---|
| . | Baseline . | CPT . | CPTmax . | Recovery . | Group β (P-value) . | Exposure β (P-value) . | β (P-value) . | Group × exposure β (P-value) . |
| SBP (mmHg) | ||||||||
| NT | 121 ± 9 | 136 ± 14 | 146 ± 18 | 127 ± 14 | 29.91 (P < .001) | 26.99 (P < .001) | Group: 27.08 (P < .001) | BL vs CPTmax: No interaction |
| HT | 148 ± 15 | 167 ± 24 | 178 ± 28 | 155 ± 16 | BL vs CPTmax: 24.38 (P < .001) | 5.64 (P = .228) | ||
| DBP (mmHg) | ||||||||
| NT | 70 ± 9 | 84 ± 13 | 92 ± 16 | 77 ± 10 | 20.68 (P < .001) | 21.54 (P < .001) | Group: 20.76 (P < .001) | BL vs CPTmax: No interaction |
| HT | 91 ± 11 | 106 ± 18 | 113 ± 19 | 96 ± 12 | BL vs CPTmax: 21.62 (P < .001) | –0.174 (P = .964) | ||
| MBP (mmHg) | ||||||||
| NT | 89 ± 10 | 105 ± 14 | 114 ± 17 | 97 ± 11 | 25.30 (P < .001) | 25.31 (P < .001) | Group: 24.74 (P < .001) | BL vs CPTmax: No interaction |
| HT | 114 ± 12 | 132 ± 21 | 140 ± 23 | 120 ± 13 | BL vs CPTmax: 24.80 (P < .001) | 1.11 (P = .801) | ||
| HR (b.p.m.) | ||||||||
| NT | 63 ± 10 | 76 ± 14 | 74 ± 14 | 63 ± 10 | –2.88 (P = .207) | 9.17 (P < .001) | Group: –1.47 (P = .575) | BL vs CPTmax: No interaction |
| HT | 62 ± 7 | 70 ± 12 | 69 ± 12 | 61 ± 7 | BL vs CPTmax: 10.47 (P < .001) | –2.79 (P = .296) | ||
| . | . | . | . | . | Univariate analysis . | Adjusted analysis . | ||
|---|---|---|---|---|---|---|---|---|
| . | Baseline . | CPT . | CPTmax . | Recovery . | Group β (P-value) . | Exposure β (P-value) . | β (P-value) . | Group × exposure β (P-value) . |
| SBP (mmHg) | ||||||||
| NT | 121 ± 9 | 136 ± 14 | 146 ± 18 | 127 ± 14 | 29.91 (P < .001) | 26.99 (P < .001) | Group: 27.08 (P < .001) | BL vs CPTmax: No interaction |
| HT | 148 ± 15 | 167 ± 24 | 178 ± 28 | 155 ± 16 | BL vs CPTmax: 24.38 (P < .001) | 5.64 (P = .228) | ||
| DBP (mmHg) | ||||||||
| NT | 70 ± 9 | 84 ± 13 | 92 ± 16 | 77 ± 10 | 20.68 (P < .001) | 21.54 (P < .001) | Group: 20.76 (P < .001) | BL vs CPTmax: No interaction |
| HT | 91 ± 11 | 106 ± 18 | 113 ± 19 | 96 ± 12 | BL vs CPTmax: 21.62 (P < .001) | –0.174 (P = .964) | ||
| MBP (mmHg) | ||||||||
| NT | 89 ± 10 | 105 ± 14 | 114 ± 17 | 97 ± 11 | 25.30 (P < .001) | 25.31 (P < .001) | Group: 24.74 (P < .001) | BL vs CPTmax: No interaction |
| HT | 114 ± 12 | 132 ± 21 | 140 ± 23 | 120 ± 13 | BL vs CPTmax: 24.80 (P < .001) | 1.11 (P = .801) | ||
| HR (b.p.m.) | ||||||||
| NT | 63 ± 10 | 76 ± 14 | 74 ± 14 | 63 ± 10 | –2.88 (P = .207) | 9.17 (P < .001) | Group: –1.47 (P = .575) | BL vs CPTmax: No interaction |
| HT | 62 ± 7 | 70 ± 12 | 69 ± 12 | 61 ± 7 | BL vs CPTmax: 10.47 (P < .001) | –2.79 (P = .296) | ||
Data are presented as mean ± SD.
CPTmax: maximal CPT; BL, baseline.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
